Skip to main content
S&P 5007,685.67+0.81%DOW52,331.51+0.22%NASDAQ26,240.81+1.10%BTC$80,659.00+0.07%ETH$2,336.04-0.33%GOLD$4,033.70+0.64%OIL$101.80-1.42%
Smart Investors Daily
SID Premium
InnovAge Holding Corp. logo

NASDAQ · INNV

InnovAge Holding Corp.

Healthcare · Medical - Care Facilities

$9.55

Up+$0.03 (+0.31%)

Updated Oct 26, 2026, 2:54 PM

SID Score

5.6/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
724.13M
P/E ratio
-41.77
Dividend yield
0.00%
52-week range
$3.94 – $12.64
Volume
460.86K
Avg. volume
130.78K

Price performance · INNV

INNV price history

1M range · 20 trading sessions · Daily adjusted prices

Prices through Oct 23, 2026

INNV closed at $9.55 after 20 trading sessions, up 7.42% for the selected period.

Last close
$9.55
Period change
+7.42%
Period low
$8.80
Period high
$9.55
Daily close
View OHLC price history
INNV OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Oct 23, 2026$9.53$9.70$9.396$9.55460.86K
Oct 22, 2026$9.07$9.54$9.05$9.52950.83K
Oct 21, 2026$9.17$9.29$9.04$9.14551.87K
Oct 20, 2026$8.94$9.27$8.83$9.151.97M
Oct 19, 2026$8.88$8.96$8.81$8.88288.78K
Oct 16, 2026$9.02$9.08$8.79$8.85381.99K
Oct 15, 2026$9.18$9.225$8.915$8.98307.89K
Oct 14, 2026$8.95$9.12$8.935$9.08357.54K
Oct 13, 2026$9.17$9.23$8.945$9.02460.71K
Oct 12, 2026$9.04$9.22$9.04$9.15315.39K
Oct 9, 2026$9.11$9.27$9.08$9.10343.09K
Oct 8, 2026$9.18$9.18$8.91$9.111.18M
Oct 7, 2026$8.91$9.195$8.91$9.13342.16K
Oct 6, 2026$9.01$9.16$8.89$9.00362.37K
Oct 5, 2026$9.01$9.075$8.84$9.00878.3K
Oct 2, 2026$8.90$9.08$8.74$8.961.18M
Oct 1, 2026$8.78$9.00$8.60$8.80461.96K
Sep 30, 2026$8.95$8.95$8.72$8.80807.59K
Sep 29, 2026$8.80$9.00$8.69$8.98729.15K
Sep 28, 2026$8.99$9.26$8.82$8.89725.52K

Latest INNV news

The latest Smart Investors Daily articles mentioning INNV.

Stock researchCompany · Overview

INNV research

Overview

Company profile and research snapshot.

Company profile

InnovAge Holding Corp is a healthcare delivery platform comprising multiple participants focused on providing all-inclusive, capitated care to high-cost seniors, many of whom are dual-eligible. Its programs are designed to address two of the pressing challenges facing the U.S. healthcare industry: rising costs and poor outcomes. The purpose of the participant-centered care delivery approach is to improve the quality of care participants receive, while keeping them in their homes for as long as possible and reducing the overutilization of high-cost care settings, such as hospitals and nursing homes. The company manages its business as one reportable segment, PACE.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
$6.80
Implied upside
—
Analysts
—
INNV recent ratings
DateFirmRatingTarget
Sep 9, 2026KeybancOverweight—
Aug 21, 2026KeybancOverweight—
Feb 23, 2026JP MorganUnderweight—
Dec 17, 2024JP MorganUnderweight—
Oct 11, 2024KeybancSector Weight—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Oct 20, 2026

InnovAge to Announce Fiscal First Quarter 2027 Financial Results and Host Conference Call Tuesday, November 3, 2026

DENVER, Oct. 20, 2026 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (“InnovAge” or the “Company”) (Nasdaq: INNV), an industry leader in providing comprehensive healthcare programs to frail, and predominantly dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE), today announced it will release its 2027 fiscal first quarter financial results on Tuesday, November 3, 2026, after market close. In conjunction, the Company will host a conference call to review the results

Yahoo · Sep 27, 2026

InnovAge Holding (INNV), Why Is It Getting Fresh Attention?

InnovAge Holding (INNV) completed a US$92.5m follow-on equity offering of 10,000,000 common shares on 22 September 2026, pricing the new stock at US$9.25 with a US$0.4625 discount per share. InnovAge Holding’s latest US$9.00 share price comes after a 1-day share price return of 1.81%, but the stock is down 17.13% over 30 days and 22.48% over 90 days, even with a 73.41% year-to-date share price return and 87.5% 1-year total shareholder return that hint at earlier momentum cooling as investors...

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By